A systematic review examining studies on BPC-157 and musculoskeletal healing found that the vast majority were preclinical (primarily conducted in rats), with very limited clinical data in humans
Commonly Studied with TB-500 BPC-157 is frequently researched alongside TB-500 due to their complementary biological profiles
Research shows it may be effective for several chronic diseases, including diabetes, cardiovascular disorders and inflammatory diseases
Oxidative Stress, Cell Activation and Viral Infection 1994;101-11
In line with this observation, the pre-administration of DSePA (2 mg/Kg bodyweight) for five consecutive days significantly improved the 30-day survival of mice against the lethal dose (-rays, 10 Gy) of WBI by preventing lipid peroxidation, DNA damage, and apoptosis in the radiosensitive organs like the spleen and small intestine [88, 89]